SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-112470
Filing Date
2021-09-02
Accepted
2021-09-02 16:01:51
Documents
2
Period of Report
2021-08-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2126885-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2126885-1_3seq1.xml 3 3936
2 POWER OF ATTORNEY tm2126885d1_ex24.htm EX-24 3781
  Complete submission text file 0001104659-21-112470.txt   9495
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 3 UNIVERSITY PLAZA DRIVE, SUITE 320 HACKENSACK NJ 07601
Business Address
Patlis Alla (Reporting) CIK: 0001639227 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36641 | Film No.: 211233221